p53 Invest

Overview

p53 Invest is a Norwegian venture capital firm specializing in early-stage investments within the healthcare sector. The firm focuses on identifying and supporting companies that are developing groundbreaking ideas to transform healthcare and improve patient outcomes. Their portfolio includes companies in biotechnology and medical devices, aiming to enhance accessibility to cutting-edge treatments and innovative healthcare solutions. The firm's investment strategy involves close collaboration with entrepreneurs and management teams to build competitive healthcare companies. p53 Invest provides long-term capital and contributes knowledge, experience, and networking through active ownership. They seek companies founded on strong science and technologies, aiming to disrupt the status quo and contribute to better and more sustainable healthcare solutions. p53 Invest's portfolio includes companies such as Valink Therapeutics, Calluna Pharma, and Teitur Trophics. These investments reflect the firm's commitment to supporting innovative healthcare solutions that address unmet medical needs and improve quality of life for patients. The firm operates with a strong belief in long-term value creation and active involvement in the development and commercialization of its portfolio companies.

Investment Focus

• Strong scientific foundation
• Innovative healthcare solutions
• Potential for global impact
• Experienced management teams

Portfolio Companies